Current and novel pharmacologic approaches in advanced heart failureO'CONNOR, C. M; GATTIS, W. A; SWEDBERG, K et al.Heart & lung. 1999, Vol 28, Num 4, pp 227-242, issn 0147-9563Article

Possible interaction involving phenytoin, dexamethasone, and antineoplastic agents : A case report and reviewGATTIS, W. A; MAY, D. B.The Annals of pharmacotherapy. 1996, Vol 30, Num 5, pp 520-526, issn 1060-0280Article

Therapeutic range of digoxin's efficacy in heart failure : What is the evidence?TERRA, S. G; WASHAM, J. B; DUNHAM, G. D et al.Pharmacotherapy. 1999, Vol 19, Num 10, pp 1123-1126, issn 0277-0008Conference Paper

A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure : The U.S. ecadotril pilot safety studyO'CONNOR, C. M; GATTIS, W. A; KASPER, E. K et al.The American heart journal. 1999, Vol 138, Num 6, pp 1140-1148, issn 0002-8703, 1Article

A prospective, open-label study of single-dose ciprofloxacin absorption after chemotherapy in patients with malignancyGATTIS, W. A; PETROS, W. P; PICKARD, W. W et al.Pharmacotherapy. 1997, Vol 17, Num 4, pp 836-840, issn 0277-0008Article

The role of clinical nonfatal end points in cardiovascular Phase II/III clinical trialsO'CONNOR, C. M; GATTIS, W. A; RYAN, T. J et al.The American heart journal. 2000, Vol 139, Num 4, pp S143-S154, issn 0002-8703Conference Paper

Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure : Insights from the Flolan International Randomized Survival Trial (FIRST)O'CONNOR, C. M; GATTIS, W. A; CALIFF, R. M et al.The American heart journal. 1999, Vol 138, Num 1, pp 78-86, issn 0002-8703, 1Article

Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunctionBART, B. A; GATTIS, W. A; DIEM, S. J et al.The American journal of cardiology. 1997, Vol 79, Num 8, pp 1118-1120, issn 0002-9149Article

Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team : Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) studyGATTIS, W. A; HASSELBLAD, V; WHELLAN, D. J et al.Archives of internal medicine (1960). 1999, Vol 159, Num 16, pp 1939-1945, issn 0003-9926Article

Failure of thrombin generation markers to triage patients presenting with chest painMCKENZIE, M. E; POTHULA, A; GURBEL, P. A et al.Cardiology. 1999, Vol 92, Num 1, pp 53-58, issn 0008-6312Article

Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure ?GATTIS, W. A; LARSEN, R. L; HASSELBLAD, V et al.The American heart journal. 1998, Vol 136, Num 1, pp 43-48, issn 0002-8703Article

Current and novel pharmacologic approaches in advanced heart failureO'CONNOR, C. M; GATTIS, W. A; SWEDBERG, K et al.The American heart journal. 1998, Vol 135, Num 6, pp S249-S263, issn 0002-8703, 2Article